(ENTG) Entegris - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US29362U1043
Stock: Chemicals, Filters, Wafers, Gases, Pumps
Total Rating 45
Risk 79
Buy Signal -0.79
| Risk 5d forecast | |
|---|---|
| Volatility | 61.1% |
| Relative Tail Risk | -4.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.59 |
| Alpha | -25.19 |
| Character TTM | |
|---|---|
| Beta | 2.262 |
| Beta Downside | 2.286 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.93% |
| CAGR/Max DD | 0.24 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 80.8921
Description: ENTG Entegris March 01, 2026
Entegris, Inc. (NASDAQ: ENTG) supplies advanced materials and contamination-control solutions to the semiconductor and other high-technology sectors across North America, Asia, and Europe. The business is split into Materials Solutions (MS), which offers chemicals, slurries, gases and other specialty materials, and Advanced Purity Solutions (APS), which provides filtration and purification hardware for chip-making and related industries.
In its most recent fiscal year (FY 2025), Entegris generated $2.53 billion in revenue, up 9.8% year-over-year, driven by strong demand for AI-focused logic chips and advanced packaging technologies. The company posted an adjusted EBITDA margin of 18.5% and returned $210 million to shareholders via dividends and share repurchases. Capital expenditures remained disciplined at $150 million, reflecting confidence in continued growth of the semiconductor supply chain.
Key sector drivers include the accelerating rollout of 5G infrastructure, rising investment in autonomous-vehicle electronics, and ongoing shortages of high-purity materials that favor suppliers with robust contamination-control capabilities-areas where Entegris’ APS segment is well positioned.
For a deeper dive into the stock’s valuation metrics, you might explore ValueRay’s platform.
Headlines to watch out for
- Semiconductor capital expenditure directly impacts Entegris revenue
- Memory and logic chip demand drives materials sales
- Supply chain disruptions increase manufacturing costs
- Geopolitical tensions affect global semiconductor market
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 235.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.07 > 1.0 |
| NWC/Revenue: 35.96% < 20% (prev 33.66%; Δ 2.30% < -1%) |
| CFO/TA 0.08 > 3% & CFO 695.4m > Net Income 235.6m |
| Net Debt (3.53b) to EBITDA (866.4m): 4.08 < 3 |
| Current Ratio: 3.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (152.5m) vs 12m ago 0.39% < -2% |
| Gross Margin: 43.02% > 18% (prev 0.46%; Δ 4.26k% > 0.5%) |
| Asset Turnover: 38.18% > 50% (prev 38.61%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: 2.49 > 6 (EBITDA TTM 866.4m / Interest Expense TTM 191.9m) |
Altman Z'' 2.25
| A: 0.14 (Total Current Assets 1.64b - Total Current Liabilities 488.6m) / Total Assets 8.35b |
| B: 0.19 (Retained Earnings 1.56b / Total Assets 8.35b) |
| C: 0.06 (EBIT TTM 477.1m / Avg Total Assets 8.37b) |
| D: 0.34 (Book Value of Equity 1.49b / Total Liabilities 4.40b) |
| Altman-Z'' Score: 2.25 = BBB |
Beneish M -3.15
| DSRI: 0.87 (Receivables 458.7m/534.9m, Revenue 3.20b/3.24b) |
| GMI: 1.07 (GM 43.02% / 45.87%) |
| AQI: 0.98 (AQ_t 0.59 / AQ_t-1 0.60) |
| SGI: 0.99 (Revenue 3.20b / 3.24b) |
| TATA: -0.06 (NI 235.6m - CFO 695.4m) / TA 8.35b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of ENTG shares?
As of March 15, 2026, the stock is trading at USD 116.18 with a total of 2,246,037 shares traded.
Over the past week, the price has changed by -3.70%, over one month by -17.61%, over three months by +20.52% and over the past year by +15.17%.
Over the past week, the price has changed by -3.70%, over one month by -17.61%, over three months by +20.52% and over the past year by +15.17%.
Is ENTG a buy, sell or hold?
Entegris has received a consensus analysts rating of 4.44.
Therefore, it is recommended to buy ENTG.
- StrongBuy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ENTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 142.7 | 22.9% |
| Analysts Target Price | 142.7 | 22.9% |
ENTG Fundamental Data Overview March 14, 2026
P/E Trailing = 80.8921
P/E Forward = 37.8788
P/S = 5.3431
P/B = 4.9565
P/EG = 1.6532
Revenue TTM = 3.20b USD
EBIT TTM = 477.1m USD
EBITDA TTM = 866.4m USD
Long Term Debt = 3.70b USD (from longTermDebt, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last quarter)
Debt = 3.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 20.61b USD (17.08b + Debt 3.89b - CCE 360.4m)
Interest Coverage Ratio = 2.49 (Ebit TTM 477.1m / Interest Expense TTM 191.9m)
EV/FCF = 36.12x (Enterprise Value 20.61b / FCF TTM 570.7m)
FCF Yield = 2.77% (FCF TTM 570.7m / Enterprise Value 20.61b)
FCF Margin = 17.85% (FCF TTM 570.7m / Revenue TTM 3.20b)
Net Margin = 7.37% (Net Income TTM 235.6m / Revenue TTM 3.20b)
Gross Margin = 43.02% ((Revenue TTM 3.20b - Cost of Revenue TTM 1.82b) / Revenue TTM)
Gross Margin QoQ = 38.35% (prev 43.53%)
Tobins Q-Ratio = 2.47 (Enterprise Value 20.61b / Total Assets 8.35b)
Interest Expense / Debt = 1.15% (Interest Expense 44.9m / Debt 3.89b)
Taxrate = 10.02% (5.50m / 54.9m)
NOPAT = 429.3m (EBIT 477.1m * (1 - 10.02%))
Current Ratio = 3.35 (Total Current Assets 1.64b / Total Current Liabilities 488.6m)
Debt / Equity = 0.98 (Debt 3.89b / totalStockholderEquity, last quarter 3.95b)
Debt / EBITDA = 4.08 (Net Debt 3.53b / EBITDA 866.4m)
Debt / FCF = 6.19 (Net Debt 3.53b / FCF TTM 570.7m)
Total Stockholder Equity = 3.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.81% (Net Income 235.6m / Total Assets 8.35b)
RoE = 6.12% (Net Income TTM 235.6m / Total Stockholder Equity 3.85b)
RoCE = 6.32% (EBIT 477.1m / Capital Employed (Equity 3.85b + L.T.Debt 3.70b))
RoIC = 5.55% (NOPAT 429.3m / Invested Capital 7.73b)
WACC = 11.80% (E(17.08b)/V(20.97b) * Re(14.25%) + D(3.89b)/V(20.97b) * Rd(1.15%) * (1-Tc(0.10)))
Discount Rate = 14.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.33%
[DCF] Terminal Value 65.65% ; FCFF base≈468.9m ; Y1≈472.7m ; Y5≈508.6m
[DCF] Fair Price = 10.52 (EV 5.13b - Net Debt 3.53b = Equity 1.60b / Shares 151.9m; r=11.80% [WACC]; 5y FCF grow 0.40% → 2.90% )
EPS Correlation: -56.58 | EPS CAGR: -10.47% | SUE: 1.17 | # QB: 1
Revenue Correlation: -0.32 | Revenue CAGR: 6.54% | SUE: 0.55 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.77 | Chg7d=-0.008 | Chg30d=+0.024 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-12-31): EPS=3.41 | Chg7d=+0.000 | Chg30d=+0.172 | Revisions Net=+8 | Growth EPS=+24.0% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=4.36 | Chg7d=+0.000 | Chg30d=+0.240 | Revisions Net=+4 | Growth EPS=+27.9% | Growth Revenue=+9.4%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 13.0% (Discount Rate 14.2% - Earnings Yield 1.2%)
[Growth] Growth Spread = -8.4% (Analyst 4.6% - Implied 13.0%)
P/E Forward = 37.8788
P/S = 5.3431
P/B = 4.9565
P/EG = 1.6532
Revenue TTM = 3.20b USD
EBIT TTM = 477.1m USD
EBITDA TTM = 866.4m USD
Long Term Debt = 3.70b USD (from longTermDebt, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last quarter)
Debt = 3.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 20.61b USD (17.08b + Debt 3.89b - CCE 360.4m)
Interest Coverage Ratio = 2.49 (Ebit TTM 477.1m / Interest Expense TTM 191.9m)
EV/FCF = 36.12x (Enterprise Value 20.61b / FCF TTM 570.7m)
FCF Yield = 2.77% (FCF TTM 570.7m / Enterprise Value 20.61b)
FCF Margin = 17.85% (FCF TTM 570.7m / Revenue TTM 3.20b)
Net Margin = 7.37% (Net Income TTM 235.6m / Revenue TTM 3.20b)
Gross Margin = 43.02% ((Revenue TTM 3.20b - Cost of Revenue TTM 1.82b) / Revenue TTM)
Gross Margin QoQ = 38.35% (prev 43.53%)
Tobins Q-Ratio = 2.47 (Enterprise Value 20.61b / Total Assets 8.35b)
Interest Expense / Debt = 1.15% (Interest Expense 44.9m / Debt 3.89b)
Taxrate = 10.02% (5.50m / 54.9m)
NOPAT = 429.3m (EBIT 477.1m * (1 - 10.02%))
Current Ratio = 3.35 (Total Current Assets 1.64b / Total Current Liabilities 488.6m)
Debt / Equity = 0.98 (Debt 3.89b / totalStockholderEquity, last quarter 3.95b)
Debt / EBITDA = 4.08 (Net Debt 3.53b / EBITDA 866.4m)
Debt / FCF = 6.19 (Net Debt 3.53b / FCF TTM 570.7m)
Total Stockholder Equity = 3.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.81% (Net Income 235.6m / Total Assets 8.35b)
RoE = 6.12% (Net Income TTM 235.6m / Total Stockholder Equity 3.85b)
RoCE = 6.32% (EBIT 477.1m / Capital Employed (Equity 3.85b + L.T.Debt 3.70b))
RoIC = 5.55% (NOPAT 429.3m / Invested Capital 7.73b)
WACC = 11.80% (E(17.08b)/V(20.97b) * Re(14.25%) + D(3.89b)/V(20.97b) * Rd(1.15%) * (1-Tc(0.10)))
Discount Rate = 14.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.33%
[DCF] Terminal Value 65.65% ; FCFF base≈468.9m ; Y1≈472.7m ; Y5≈508.6m
[DCF] Fair Price = 10.52 (EV 5.13b - Net Debt 3.53b = Equity 1.60b / Shares 151.9m; r=11.80% [WACC]; 5y FCF grow 0.40% → 2.90% )
EPS Correlation: -56.58 | EPS CAGR: -10.47% | SUE: 1.17 | # QB: 1
Revenue Correlation: -0.32 | Revenue CAGR: 6.54% | SUE: 0.55 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.77 | Chg7d=-0.008 | Chg30d=+0.024 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-12-31): EPS=3.41 | Chg7d=+0.000 | Chg30d=+0.172 | Revisions Net=+8 | Growth EPS=+24.0% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=4.36 | Chg7d=+0.000 | Chg30d=+0.240 | Revisions Net=+4 | Growth EPS=+27.9% | Growth Revenue=+9.4%
[Analyst] Revisions Ratio: +0.25 (5 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 13.0% (Discount Rate 14.2% - Earnings Yield 1.2%)
[Growth] Growth Spread = -8.4% (Analyst 4.6% - Implied 13.0%)